Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

46.93% acceptance of Fortum’s Uniper-offer - additional acceptance period to commence

FORTUM CORPORATION STOCK EXCHANGE RELEASE 19 JANUARY 2018 AT 11:00 EET The number of shares tendered during the initial acceptance period of Fortum's voluntary public takeover offer for the outstanding shares of Uniper totalled 171,736,647 shares. This corresponds to approximately 46.93% of the share capital and the voting rights of Uniper. The initial acceptance period ended on 16 January 2018. Uniper shareholders who have not yet tendered their shares to the offer within the initial acceptance period can still tender during the additional acceptance period beginning on 20 January

Proposals of Atria Plc's nomination board for the annual general meeting

Atria Plc  Company Announcement   19 January 2018, at 11.00Proposals of Atria Plc's nomination board for the annual general meetingThe Nomination Board elected Jukka Kaikkonen as Chairman from among its members. The Nomination Board's proposal concerning the number of the members of the Board of DirectorsThe Nomination Board has decided to propose to the General Meeting that a total of eight members be elected to the Board of Directors.The Nomination Board's proposal concerning the members of the Board of DirectorsThe Nomination Board has decided to propose to the General

NetEnt announces Jumanji as its latest branded game deal in collaboration with Sony Pictures Entertainment.

NetEnt, the leading provider of digital gaming solutions, has signed an agreement with Sony Pictures Consumer Products to launch a video slot machine game based on the original Jumanji film. The new Jumanji game, which will be released later this year, follows the recent launch of the holiday blockbuster film ‘Jumanji: Welcome to the Jungle’. The current film has resonated with critics and audiences alike around the globe having delivered more than $676 million in global box office.  Henrik Fagerlund, Chief Product Officer of NetEnt, said: “Being able to secure a deal for

Heiko Chudzick appointed Executive Vice President

Hexagon Composites ASA has appointed Heiko Chudzick as the Group's new Executive Vice President - Operations. Mr. Chudzick brings 20 years of progressive operational experience including leadership roles with ThyssenKrupp and Bosch. Most recently, Heiko served as Vice President Bosch Production Systems, at Robert Bosch Automotive Steering GmbH, Germany. He holds a degree in Mechanical Engineering and a major in Automotive Engineering from RWTH Aachen University (Rheinisch-Westfalische Technische Hochschule Aachen) and has extensive international experience including multi-cultural start-

Arab Health 2018 – seca advances digital transformation // Fully integrated system solutions for more safety and efficiency

WLAN baby scale seca 333 i // Interface Module seca 452Hamburg/Dubai, 19 January 2018 – Digitalization in the world of medicine is one of the trending topics at Arab Health 2018. From 29 January to 1 February in Hall 2 at Stand C19 seca will show how the newest integration solutions in medical measuring and weighing simplify labor and time-consuming procedures such as data capture, documentation and archiving and also increase efficiency and safety in everyday hospital work. Other highlights including the vital data monitor seca mVSA (medical Vital Signs Analyzer), seca mBCA (medical Body

Invitation – Year-End Report presentation

Husqvarna Group’s Year-End Report for 2017 will be published around 08:00 CET on February 2. The report and conference call slides will be available at www.husqvarnagroup.com/ir. Results presentation, conference call and audio cast at 10:00 CETFinancial analysts and media are invited to a presentation of the results at 10:00 CET the same day, hosted by Kai Wärn, President and CEO and Jan Ytterberg, CFO. The presentation will be held at Husqvarna Group’s office at Regeringsgatan 28 in Stockholm. Dial in details and audio web castTo participate by phone, dial +46 (0) 8 503 364 34 (

Tokmanni Group Corporation: Tokmanni Group Corporation will publish its financial statements bulletin for January-December 2017 on February 9th, 2018

Tokmanni Group Corporation                      IR news          19.1.2018 10 am EET      Tokmanni will publish its financial statements bulletin for January-December 2017 on February 9th, 2018 at approximately 8.30 a.m. EET (7.30 CET). The stock exchange release and the presentation materials in Finnish and in English will be available on the company's website at ir.tokmanni.fi as soon as possible after the publication of the report.  Analyst and press conference  An analyst and press conference will be held on the publication at 10.00 am EET at the GLO Hotel, Kluuvikatu 4,

Loomis expands its international business

Loomis has, through one of its wholly owned subsidiaries, acquired 100 per cent of the business of Sequel International Logistics (USA) Inc. from Sequel Logistics Pvt. Ltd (“Sequel”), the largest secure logistics company in India. The enterprise value, i.e. purchase price plus acquired net debt, is approximately USD 2 million, corresponding to approximately SEK 16.5 million. Sequel International Logistics (USA) Inc. has approximately 15 employees and the annual revenue in 2017 was approximately USD 2.6 million. The business will be reported in segment International and consolidated

Q4 and full year 2017 results conference call

MTG will publish its Q4 and full year 2017 financial results at 07:00 CET on Thursday 1 February, and will hold a conference call at 09:00 CET the same day. The call will be hosted by Jørgen Madsen Lindemann (President & CEO) and Maria Redin (CFO).To participate, please dial: Sweden:               +46 (0)8 5033 6574 UK:                        +44 (0)330 336 9105 US:                        +1 323-794-2093 The access pin code for the call is 4817696  To ensure that the conference call starts on time, please dial in 5-10 minutes before the scheduled start time. The conference

Smart insole developer MoveSole Ltd signs notable distribution deal for Northern and Central Europe

PRESS RELEASE Helsinki 19 Jan 2018 – MoveSole Ltd, a Finnish company developing smart insoles for health care professionals has agreed on a comprehensive distribution deal for Northern and Central Europe with Mobility Research Denmark.As of today, Movesole and Mobility Research Denmark have a distribution contract regarding Mobility Research Denmark’s sales for MoveSole products in Germany, France, Belgium, Sweden, Denmark and Norway. According to Michael Skivensen, the CEO of Mobility Research Denmark, MoveSole Steplab perfectly complements LiteGait and NuStep product portfolios. He is

Dome Energy AB gives financial update; Sale of non-core assets provides proceeds of MSEK 28

Dome Energy AB.  (herein after “Dome” and/or “the Company”) reports the sale of non-core assets, and receives SEK 28,000,000 in net proceeds. Dome has entered into an agreement to sell its interest in one producing well in Louisiana. The sale will result in a reduction of around 65 BOEPD production, and all proceeds will be used for down payment on debt. Paul Morch, CEO: “We are happy to have negotiated a good price for the sale of this asset. Recent oil price movements have allowed a higher valuation than we have recently seen, and we felt it was the right

INVISIO Awarded Danish Defense Contract

Stockholm, January 19, 2018 INVISIO has signed a framework agreement with the Danish Defence Acquisition and Logistics Organization (DALO), to supply communication systems to the Danish Army. The agreement is for five years with options for another two years.Collaboration with DALO and the Danish Army on a larger scale, began in 2012 when INVISIO's communications system was integrated with the army's new tactical radio to increase the safety and operational effectiveness of soldiers, and to reduce the risk of hearing damage.”The Danish Army is a very important customer for us and our

Cxense to provide data management software to leading global commercial data provider

Oslo, Norway – 19 January 2018 – Cxense ASA (OSE: CXENSE) today announced that Dun & Bradstreet, the global leader in commercial data, analytics and insights for businesses, entered into an agreement with Cxense for use of its data management software.   Dun & Bradstreet offers a wide range of products and services for credit, risk and supply chain management, sales acceleration and marketing solutions, as well as research and insights on global business issues.  The company’s database contains more than 280 million business records, derived from more than 30,000 sources in over 220

Cantargia’s European patent for solid tumours remains in force

The opposition proceedings at the European Patent Office (“EPO”) concerning Cantargia AB’s (“Cantargia”) patent for treatment of solid tumours have now been completed. The EPO has rejected the opposition and Cantargia’s patent is thus maintained with unchanged claims.In October 2016, a third party filed an opposition against Cantargia’s European patent no. EP 2665749 B1 directed to antibody treatment of solid tumours, such as breast cancer, colorectal cancer, lung cancer and malignant melanoma. The opposition proceedings have now been completed at the opposition division of the EPO. The

Pihlajalinna starts codetermination negotiations concerning a new structure

Pihlajalinna Plc                            Stock Exchange Release                                      19 January 2018 at 9:10 Pihlajalinna starts codetermination negotiations concerning a new structure Pihlajalinna Plc plans to renew its structure during early 2018. The company considers changing its operating model from business based organisation to geographical organisation. The company sees that the change would improve its operational preconditions and competitive position. Pihlajalinna’s current organisation consists of two business segments: Private Clinics and Specialised

Finnair chosen as airline partner during the EU-China Tourism Year 2018

Finnair is proud to cooperate as a selected airline partner to the EU - China Tourism Year 2018.  The EU - China Tourism Year focuses on developing travel between China and Europe. The main priorities of the tourism year include improving the travel and tourism experiences of travelers while visiting the EU and China, organizing business to business networking opportunities for tourist partners and facilitating business summits as well as supporting various marketing campaigns. “Finnair highly supports the EU - China Tourism Year with China being a strategic market for us. The objectives

LYNPARZA APPROVED IN JAPAN FOR OVARIAN CANCER

19 January 2018 07:00 GMT LYNPARZA RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ADVANCED OVARIAN CANCER Lynparza is the first PARP inhibitor approved in Japan Lynparza tablets approved as maintenance treatment for women with platinum-sensitive relapsed ovarian cancer regardless of BRCA mutation status AstraZeneca and Merck & Co., Inc., Kenilworth, NJ, US (known as MSD outside the US and Canada) today announced that the Japanese Ministry of Health, Labour and Welfare has approved Lynparza (olaparib) tablets (300mg twice daily) for use as a maintenance therapy for patients with

Nomination Committee for the 2018 Annual General Meeting

In September 2017 at an extraordinary General Meeting, Balco adopted an instruction regarding the appointment of the Nomination Committee, applicable until the General Meeting resolves otherwise. Pursuant to this instruction the company shall have a Nomination Committee comprising one representative for each of the four principal shareholders in terms of votes, based on the information received from Euroclear Sweden AB on the last banking day in December 2017 for AGM 2018 (for coming years on the last day of August), as well as the Chairman of the Board (convenor). The Nomination

Factor that doubles the risk of death from breast cancer identified

[PRESS RELEASE 2018-01-19] Researchers at Karolinska Institutet in Sweden have discovered that the risk of death from breast cancer is twice as high for patients with high heterogeneity of the oestrogen receptor within the same tumour as compared to patients with low heterogeneity. The study, which is published in The Journal of the National Cancer Institute, also shows that the higher risk of death over a span of 25 years is independent of other known tumour markers and also holds true for Luminal A breast cancer, a subtype with a generally good prognosis.The most common form of breast

MTG sells stake in TRACE media group

· MTG sells its 75% shareholding in TRACE media group to TPG Growth · Sale reflects MTG’s ongoing strategic transformation   MTG has signed an agreement to sell its 75% shareholding in TRACE PARTNERS S.A.S. (TRACE) to TPG Growth. The transaction values 100% of the business at an enterprise value of EUR 40 million (approximately SEK 392 million) and closing is subject to regulatory approvals. TRACE is part of MTG’s International Entertainment operations. Jørgen Madsen Lindemann, MTG President & CEO: “TRACE is a great business that we have enjoyed developing together with its

Bina Bawi and Miran West gas resource update

19 January 2018 Genel Energy plc Bina Bawi and Miran West gas resource update Genel Energy (‘Genel’ or ‘the Company’) is pleased to announce that RPS Energy Consultants Ltd. (‘RPS’), as part of its work on the updated competent person’s reports (‘CPRs’) for the Bina Bawi and Miran West fields (Genel 100% and operator), has finalised its evaluation of the contingent gas resources at both assets: ·The RPS evaluation confirms a significant upgrade to the combined 2C gross (100% working interest (‘WI’)) raw gas resource estimate for the Bina Bawi and Miran West fields: ·

ASTRAZENECA'S FASENRA RECEIVES APPROVAL

19 January 2018 07:00 GMT FASENRA RECEIVES APPROVAL IN JAPAN Approval based on Phase III WINDWARD programme that demonstrated significant reductions in asthma exacerbations, improvements in lung function and reductions in oral corticosteroid use from baseline, versus placebo Fasenra is the first approved respiratory biologic with an 8-week maintenance dosing schedule AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the Japanese Ministry of Health, Labour and Welfare has approved Fasenra (benralizumab) as an add-on treatment

There are no items matching the current filter
There are no more items matching the current filter
Back to top